HCC Group | Cirrhotic Group | Control Group | X2 | P Value | |
D.M. | 5 (25%) | 1 (5%) | 1 (5%) | 5.175 | 0.075 |
HTN | 3 (15%) | 1 (5%) | 2 (10%) | 1.111 | 0.573 |
Bilharziasis | 4 (20%) | 4 (20%) | 1 (5%) | 2.352 | 0.308 |
HBV | 2 (10%) | 0 | 0 | 4.137 | 0.126 |
HCV | 9 (45%) | 20 (100%) | 0 | 40.177 | <0.001* |
History of Hepatic encephalopathy | 4 (20%) | 0 | 0 | 8.571 | 0.013* |
Jaundice | 3 (15%) | 0 | 0 | 6.315 | 0.042* |
Pallor | 3 (15%) | 0 | 0 | 6.315 | 0.042* |
Hepatomegaly | 2 (10%) | 3 (15%) | 0 | 3.054 | 0.217 |
Splenomegaly | 9 (45%) | 0 | 0 | 21.176 | <0.001* |
Ascites | 6 (30%) | 0 | 0 | 13.333 | 0.0013* |
L.L. edema | 8 (40%) | 0 | 0 | 18.461 | <0.001* |
CTP score | |||||
A | 8 (40%) | 20 (100%) | - | - | - |
B | 8 (40%) | 0 | |||
C | 4 (20%) | 0 | |||
X2 | 30 | ||||
P value | <0.001* |